TradeFlare's AI research teams analysed CVS on 19 market nights between May 7, 2026 and August 5, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| August 5, 2026 | BUY | $104.42 | — / — | -4.4% | -1.9% | Upcoming earnings report to provide clarity on performance and future outlook. |
| August 4, 2026 | HOLD | $105.37 | — / — | -10.5% | -6.5% | Continued integration of recent acquisitions and strategic growth initiatives. |
| August 3, 2026 | BUY | $104.43 | — / — | -9.2% | -10.9% | Strong earnings growth driven by improved profitability. |
| July 31, 2026 | HOLD | $105.22 | — / — | -8.4% | -10.9% | Continued integration success of recent acquisitions. |
| July 30, 2026 | BUY | $105.92 | — / — | -8.6% | -11.7% | Strong earnings growth and potential undervaluation based on forward P/E. |
| July 29, 2026 | BUY | $109.34 | — / — | -6.4% | -10.9% | Continued positive news sentiment driven by strong financial results and strategic service expansions. |
| July 28, 2026 | BUY | $107.07 | $123.13 / $90.91 | -4.5% | -15.0% | The bullish fundamental and sentiment teams, combined with a neutral technical outlook, suggest a short-to-medium term trading opportunity. |
| July 23, 2026 | BUY | $108.08 | $124.29 / $97.27 | -1.6% | -12.4% | The technical setup and fundamental strength suggest a multi-week move. |
| July 22, 2026 | BUY | $110.60 | — / — | -2.0% | -13.3% | Continued positive sentiment driven by strong financial performance and strategic initiatives. |
| July 21, 2026 | HOLD | $107.61 | — / — | -1.1% | -14.2% | The current market and stock-specific conditions do not warrant a new position. |
| July 20, 2026 | BUY | $107.47 | — / — | -0.5% | -12.6% | Continued revenue and earnings growth driven by integrated model. |
| July 17, 2026 | BUY | $106.50 | — / — | +0.2% | -9.6% | The current market and stock-specific signals do not provide a clear directional conviction for a trade. |
| July 16, 2026 | BUY | $105.91 | — / — | +0.4% | -10.8% | The current market and stock-specific factors do not present a clear, high-conviction trading opportunity. |
| July 15, 2026 | BUY | $106.18 | — / — | +2.0% | -10.6% | Continued strong revenue and earnings growth from CVS Health's integrated model. |
| June 24, 2026 | BUY | $101.57 | $121.88 / $91.41 | +2.9% | +4.9% | The technical setup suggests a potential breakout from a sideways range, and the fundamental and sentiment indicators support a bullish outlook over a medium-term horizon. |
| May 25, 2026 | BUY | $93.26 | — / — | -1.4% | +12.3% | Continued strong earnings growth and stable revenue. |
| May 14, 2026 | BUY | $98.11 | $117.73 / $83.39 | -3.9% | +5.0% | The technical setup suggests an uptrend with room for further upside, and fundamental tailwinds support a medium-term move. |
| May 8, 2026 | BUY | $87.36 | $97.50 / $78.62 | +5.9% | +7.2% | The stock is near its 52-week high with strong bullish technicals and fundamentals, suggesting a short-to-medium term upward trend. |
| May 7, 2026 | BUY Published signal · reached target +11.6% |
$86.86 | $95.55 / $78.17 | +11.2% | +9.8% | The 52-week breakout suggests momentum continuation in the short to medium term. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.